Treating Before Symptoms—ADCS Invites Ideas for Clinical Trials in Very Early AD
measure as a primary outcome in this population. Notably, a recent paper demonstrates the utility of
117 RESULTS
You searched papers/human-blood-brain-barrier-receptors-alzheimers-amyloid-beta-1-40-asymmetrical-binding
Sort By:
measure as a primary outcome in this population. Notably, a recent paper demonstrates the utility of
correct. Mark Smith Phyllis, I have read in several papers otherwise...we should discuss. Sam Gandy I was
Mesulam, 1999; Lue et al, 1999; Koudinov et al, 2001.) Also, a recent paper by a Scottish group (White, et
comments by using our Comments form at the bottom of the page. Paper Under Discussion: Neve RL and Robakis
Pasinetti: We recently submitted a paper suggesting that the overexpression in the brain of COX-2 transgenic
a longer answer; check our papers and I will talk with you about that answer later. Bye. Kiminobu Sugaya:
2000 Jul 15;25(14):1765-70. Abstract 0 we have pdf of paper Wednesday, July 6, 2005- 00:00
David and Julie's paper? Let's wrap up this topic before we move on to the next. Craig Atwood
pre-medline is out! June: I can live with that. Colin Masters: Just review the last hundred papers. Msmith:
die but without forming NFT. (paper under review). Craig Atwood: Inez, for amyloid in Niemann-Pick
paper from Herrup's lab also found that all cases with mild cognitive impairment that were tested
This is an "add-on," not a combination. Steve DeKosky The Tariot et al. paper is the only
the topic of a forthcoming paper. Our preliminary analyses suggest that participants found to be at
Alois Alzheimer made a major breakthrough when he discovered senile plaques in the brains of dementia patients, and his work ultimately led to the discovery of amyloid-β and to the amyloid cascade hypothesis. But that cascade is only part of a much bigger
On Thursday, 24 February 2011, Ruth Itzhaki, University of Manchester, U.K.; Elisa Porcellini, University of Bologna, Italy; Luc Letenneur, INSERM, Bordeaux, France, and Richard Smeyne, St. Jude Children’s Research Hospital, Memphis, Tennessee, shared som
Have a topic idea for a webinar? We would love to hear it. Send an email to webinars [at] alzforum [dot] org.